Integra LifeSciences IART Specialty Surgery — Foreign currency translation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's specialty surgery — foreign currency translation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's specialty surgery — foreign currency translation?
- Integra LifeSciences (IART) reported specialty surgery — foreign currency translation of -$1.07M in Q1 2026.
- What does specialty surgery — foreign currency translation mean?
- This metric quantifies the impact of fluctuations in foreign exchange rates on the reported financial results of the Specialty Surgery segment. It highlights the segment's exposure to international markets and the volatility associated with operating in multiple global currencies.